Evidence map›Paper›PMID 41910139›Full record

ArticleMicrobiology spectrum2026

Efficacy of a chemiluminescence-based urinary LAM (AIMLAM) assay in the diagnosis of active TB in Chinese children.

Yiyi Chen, Haiyan Li, Jing Xiao, Hui Qi, Jie Kang, Qifeng Li, Jingjing Li, Min Fang, Li Duan, Xiaomeng Wu and 2 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yiyi ChenLaboratory of Respiratory Diseases, Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China.
Haiyan LiDepartment of Pediatric Pulmonology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Jing XiaoLaboratory of Respiratory Diseases, Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China.
Hui QiLaboratory of Respiratory Diseases, Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China.
Jie KangLaboratory of Respiratory Diseases, Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China.
Qifeng LiDepartment of Science and Education, Xinjiang Institute of Pediatrics, Xinjiang Hospital of Beijing Children's Hospital, Children's Hospital of Xinjiang Uygur Autonomous Region, The Seventh People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Jingjing LiLaboratory of Respiratory Diseases, Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China.
Min FangThe Seventh People's Hospital of Liangshan Yizu Autonomous Prefecture, Liangshan, Sichuan, China.
Li DuanThe Seventh People's Hospital of Liangshan Yizu Autonomous Prefecture, Liangshan, Sichuan, China.
Xiaomeng WuLaboratory of Respiratory Diseases, Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China.
Hailin ZhangDepartment of Pediatric Pulmonology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.ORCID 0000-0002-7663-0418
Lin SunLaboratory of Respiratory Diseases, Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China.ORCID 0000-0003-1044-2470

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Child-friendly triage tests that do not rely on sputum for diagnosing active tuberculosis (ATB) in children are urgently required. This study aimed to assess a chemiluminescence-based urinary lipoarabinomannan test (AIMLAM) for diagnosing tuberculosis (TB) in children in China. Among the 579 children enrolled, 331 had TB, 169 had infectious diseases, and 79 were healthy controls. The area under the ROC curve of the AIMLAM test for distinguishing TB from non-TB (children with infectious diseases and healthy controls) was 0.74 (95% confidence interval [CI], 0.70-0.78), with a sensitivity of 52.2% (95% CI, 46.6%-57.6%) and a specificity of 91.9% (95% CI, 87.6%-94.9%). In 288 children with clinically diagnosed TB, the sensitivity of the test was 50.0% (95% CI, 44.1%-55.9%). LAM concentrations in extrapulmonary TB were significantly higher than those in pulmonary TB ( IMPORTANCE: This study of a large-sample cohort of children in China assessed the diagnostic accuracy of the AIMLAM test kit as an auxiliary tool for childhood TB, and to determine an age-specific reference interval for LAM concentrations in children. Our findings showed that the overall sensitivity of AIMLAM was moderate, whereas a higher sensitivity was observed in patients with bacteriologically confirmed and severe TB. Age-specific cutoff values may be needed to optimize the diagnostic model in children. These results provide preliminary evidence for a method of diagnosing ATB in pediatric patients with samples that are difficult to obtain.

Indexed as

AIMLAMclinical practicediagnosticsjoint diagnosispediatric tuberculosis

Identifiers

PMID41910139
PMCPMC13141949

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.